Stockreport

How The BioCryst Pharmaceuticals (BCRX) Narrative Is Shifting With Astria Deal And FY26 Targets [Yahoo! Finance]

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations
PDF BioCryst Pharmaceuticals' fair value estimate sits at US$21.30, with the latest update keeping this price target unchanged. Analysts linking this figure to reiterated F [Read more]